Toumaz Named 'Cool Vendor' by Gartner

ToumazToumaz, the leading provider of ultra-low power wireless infrastructure for body monitoring solutions, has been named as a 'Cool Vendor' by leading analyst firm Gartner, Inc. The 'Cool Vendors in Healthcare Providers 2010' report profiles five vendors worldwide who, in Gartner's assessment, exemplify innovative and potentially transformative solutions for global healthcare providers.

The report includes a recommendation to healthcare providers to "prepare for an explosion of innovations that use the potential of low-power, low-cost sensors combined with wireless networks. Since these technologies will generate large volumes of actionable data, executives will need to consolidate data and use decision support tools to enable deeper analysis of clinical processes, resources and outcomes." The authors of the report include senior Gartner analysts Jonathan Edwards, Barry Runyon, Vi Shaffer, Thomas J. Handler, M.D., John-David Lovelock, and Wes Rishel.

Toumaz's Sensium™ is the industry's first complete system for the development of end-to-end wireless vital signs monitoring and Body Area Networks (BAN) solutions. The revolutionary Sensium system provides the ability to continuously monitor multiple vital signs in real-time and feedback high-quality information to health professionals. In November 2009, Toumaz began clinical trials of its ultra-low power, ultra-small size Sensium "digital plaster" wireless body monitor, in a study conducted by a specialist clinical research team at Imperial College London. The trial has been carried out at St Mary’s Hospital, part of Imperial College Healthcare NHS Trust, and as expected, demonstrated that high quality physiological data can be continuously and wirelessly acquired by devices enabled by the Sensium platform.

Commenting on Toumaz's inclusion in the 'Cool Vendor' report, Toumaz CEO Professor Chris Toumazou said: "We are delighted to have been selected as a 'Cool Vendor' by Gartner, and we are very pleased that the transformative potential of our Sensium platform has been acknowledged in this way." He continued: "Sensium is a truly disruptive technology that provides a unique solution to addressing the medical management challenges now faced by healthcare providers across the globe. The benefits of more frequent and better structured patient monitoring have been well understood by hospital management teams for some time however, until Sensium, the costs and inconvenience have been prohibitive. Now, Sensium is providing a technology platform to create commercially-viable, clinically robust solutions and deliver a genuine revolution in wireless body monitoring - both in and out of hospital settings. We believe our 'Cool Vendor' designation from Gartner is a pleasing recognition of our solution and approach as we progress towards widespread commercial deployment of Sensium-enabled devices."

Related news articles:

About Gartner's Cool Vendors Selection Process
Gartner's listing does not constitute an exhaustive list of vendors in any given technology area, but rather is designed to highlight interesting, new and innovative vendors, products and services. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness of a particular purpose.

Gartner defines a cool vendor as a company that offers technologies or solutions that are: Innovative, enable users to do things they couldn't do before; Impactful, have, or will have, business impact (not just technology for the sake of technology); Intriguing, have caught Gartner's interest or curiosity in approximately the past six months.

For the full Gartner report, please visit: http://www.gartner.com/DisplayDocument?id=1334413&ref=g_sitelink&ref=g_SiteLink

About Sensium™
Toumaz's Sensium™ technology platform enables the non-intrusive acquisition of real-time, continuous physiological data for a wide range of health and lifestyle management applications, including remote healthcare, wellness and wireless monitoring at the bedside.

Sensium provides an open platform to develop revolutionary wireless devices that can continuously monitor multiple vital signs in real-time, and feedback high-quality information to health professionals via PCs, PDAs and smart phones.

About Toumaz
Toumaz is the leading provider of ultra-low power wireless infrastructure for body monitoring solutions.

Toumaz's ultra low-power smart sensor interface and transceiver platform - Sensium™ - enables non-intrusive, real-time wireless monitoring of multiple vital signs for a wide range of healthcare and lifestyle management applications. Based on Toumaz's patented ultra-low power Advanced Mixed Signal (AMx)™ technology, the Sensium provides the enabling technology to connect the mobile individual to healthcare providers - simply, affordably and unobtrusively.

For healthcare professionals, this transforms the possibilities for pro-active monitoring and improved quality of care. For patients, it delivers new opportunities for lifestyle-compatible, personalised healthcare, as well as better therapeutic outcomes.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...